Skip to content

Relationship between perioperative carotid blood flow monitoring and cerebral function protection in cardiac surgery

Relationship between perioperative carotid blood flow monitoring and cerebral function protection in cardiac surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064688
Enrollment
Unknown
Registered
2022-10-14
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac operation

Interventions

Group N:Nicardipine was infused during cardiopulmonary bypass
Group C:Normal saline was infused during cardiopulmonary bypass

Sponsors

Nanjing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 60-80 years old; 2. ASA II-III, NYHA I-III, EF >=50%; 3. Proposed cardiopulmonary bypass open-heart surgery (valve surgery alone or coronary artery bypass surgery).

Exclusion criteria

Exclusion criteria: 1. Patients undergoing second cardiac operation; 2. People with intellectual disability, deaf-mute or other problems affecting normal communication; 3. Previous neurosurgical operations and history of cerebral infarction; 4. Malignant tumors; 5. Patients with moderate to severe carotid artery stenosis before operation; 6. Patients with obvious abnormal liver and kidney function affecting drug metabolism; 7. People who drink alcohol, take drugs or rely on drugs; 8. Cardiopulmonary bypass time greater than 120mins; 9. Users of psychotropic drugs.

Design outcomes

Primary

MeasureTime frame
Internal carotid blood flow;

Secondary

MeasureTime frame
Regional cerebral oxygen;Neuron-specific enolase;Mini-mental State Scale score;

Countries

China

Contacts

Public ContactShi Hongwei

Nanjing First Hospital

mdshw@163.com+86 18951670892

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026